Elastrin Therapeutics

South Carolina-based biotech developing novel therapies

Elastrin Therapeutics is a South-Carolina based biotechnology start-up with technology to restore hardened and damaged arteries by targeting the elastic fibers.

Visit website: https://www.elastrin.com/

elastrin.therapeutics

elastrin

Details last updated 06-Mar-2021

People at Elastrin Therapeutics

Naren Vyavahare

Co-founder at TGenTech, Elastrin Therapeutics and Professor of Bioengineering at Clemson University

Douglas Mulhall

Co-founder of Elastrin Therapeutics

Matthias Breugelmans

Life science entrepreneur and CEO of Elastrin Therapeutics

Elastrin Therapeutics News

Reason reports back from October's Rejuvenation Startup Summit

Fight Aging! - 19-Oct-2022

Some really exciting developments with quite a few in clinical trials

Elastrin Therapeutics secures $10 million of funding for its calcification removal platform

Forever Healthy Foundation - 07-Apr-2022

Initially targeting stiffened arteries in cardiovascular disease, this could have wider implications

AgomAb raises €62M in Series B round to advance regenerative medicine

Labiotech - 16-Mar-2021

Funds to bring the experimental drug to trials; symbolizes booming regenerative niche

Elastrin's novel therapies to reverse age-related vascular damage

Longevity Technology - 04-Mar-2021

Advancing technologies for tissue and organ rejuvenation with seed funding from Kizoo